Global Irritable Bowel Syndrome (IBS) Market Research Report 2018-2030F, by Region, Type, Application/End-Use
- Published Date: 2024-08-17
- Report ID: 159546
- Pages: 150
-
Format:
Summary
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
The global Irritable Bowel Syndrome (IBS) market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
IBS-D Drug
IBS-C Drug
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Valeant Pharmaceuticals
Allergan
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Women
Men
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 Irritable Bowel Syndrome (IBS) of Research
1.1.1 Definition
1.1.2 Specifications of Irritable Bowel Syndrome (IBS)
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 IBS-D Drug Overview
1.2.1.2 IBS-C Drug Overview
1.2.1.3 Others Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Women
1.3.1.2 Men
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 IBS-D Drug Market Size 2018-2023
3.1.1.1 Global IBS-D Drug Market Size and Growth Rate 2018-2023
3.1.1.2 Global IBS-D Drug Market Size by Region 2018-2023
3.1.2 IBS-C Drug Market Size 2018-2023
3.1.2.1 Global IBS-C Drug Market Size and Growth Rate 2018-2023
3.1.2.2 Global IBS-C Drug Market Size by Region 2018-2023
3.1.3 Others Market Size 2018-2023
3.1.3.1 Global Others Market Size and Growth Rate 2018-2023
3.1.3.2 Global Others Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 IBS-D Drug Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global IBS-D Drug Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global IBS-D Drug Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 IBS-C Drug Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global IBS-C Drug Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global IBS-C Drug Market Estimates and Forecasts by Region 2024E-2030F
3.2.3 Others Market Estimates and Forecasts 2024E-2030F
3.2.3.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
3.2.3.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Women Market Size 2018-2023
4.1.1.1 Global Women Market Size and Growth Rate 2018-2023
4.1.1.2 Global Women Market Size by Region 2018-2023
4.1.2 Men Market Size 2018-2023
4.1.2.1 Global Men Market Size and Growth Rate 2018-2023
4.1.2.2 Global Men Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Women Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Women Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Women Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Men Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Men Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Men Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global Irritable Bowel Syndrome (IBS) Market Competition
7.1.1 Global Irritable Bowel Syndrome (IBS) Market by Companies
7.1.2 Global Irritable Bowel Syndrome (IBS) Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 Valeant Pharmaceuticals
8.1.1 Valeant Pharmaceuticals Company Profile
8.1.2 Valeant Pharmaceuticals Product Portfolio
8.1.3 Valeant Pharmaceuticals Business Performance
8.1.4 Valeant Pharmaceuticals Development Overview
8.2 Allergan
8.2.1 Allergan Company Profile
8.2.2 Allergan Product Portfolio
8.2.3 Allergan Business Performance
8.2.4 Allergan Development Overview
8.3 Takeda
8.3.1 Takeda Company Profile
8.3.2 Takeda Product Portfolio
8.3.3 Takeda Business Performance
8.3.4 Takeda Development Overview
8.4 Sucampo Pharmaceuticals
8.4.1 Sucampo Pharmaceuticals Company Profile
8.4.2 Sucampo Pharmaceuticals Product Portfolio
8.4.3 Sucampo Pharmaceuticals Business Performance
8.4.4 Sucampo Pharmaceuticals Development Overview
8.5 McNeil Consumer Healthcare
8.5.1 McNeil Consumer Healthcare Company Profile
8.5.2 McNeil Consumer Healthcare Product Portfolio
8.5.3 McNeil Consumer Healthcare Business Performance
8.5.4 McNeil Consumer Healthcare Development Overview
8.6 Sebela Pharmaceuticals
8.6.1 Sebela Pharmaceuticals Company Profile
8.6.2 Sebela Pharmaceuticals Product Portfolio
8.6.3 Sebela Pharmaceuticals Business Performance
8.6.4 Sebela Pharmaceuticals Development Overview
8.7 Astellas Pharmaceuticals
8.7.1 Astellas Pharmaceuticals Company Profile
8.7.2 Astellas Pharmaceuticals Product Portfolio
8.7.3 Astellas Pharmaceuticals Business Performance
8.7.4 Astellas Pharmaceuticals Development Overview
8.8 IM HealthScience
8.8.1 IM HealthScience Company Profile
8.8.2 IM HealthScience Product Portfolio
8.8.3 IM HealthScience Business Performance
8.8.4 IM HealthScience Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
